{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:00:59Z","timestamp":1780977659693,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.msard.2026.107219","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:12:24Z","timestamp":1777360344000},"page":"107219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The national neuromyelitis optica spectrum disorders registry system of Iran (NMORI): Aspects and methodological dimensions"],"prefix":"10.1016","volume":"111","author":[{"given":"Saeideh","family":"Ayoubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hora","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdorreza Naser","family":"Moghadasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2310-6375","authenticated-orcid":false,"given":"Sharareh","family":"Eskandarieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2026.107219_bib0001","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/EDE.0000000000000948","article-title":"Validation of the Swedish multiple sclerosis register: further improving a resource for pharmacoepidemiologic evaluations","volume":"30","author":"Alping","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.msard.2026.107219_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104610","article-title":"The national multiple sclerosis registry system of Iran (NMSRI): aspects and methodological dimensions","volume":"72","author":"Ayoubi","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2026.107219_bib0003","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-023-06617-y","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis","volume":"44","author":"Bagherieh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2026.107219_bib0004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/joim.12303","article-title":"Review of 103 S wedish H ealthcare Q uality R egistries","volume":"277","author":"Emilsson","year":"2015","journal-title":"J. Intern. Med"},{"issue":"2","key":"10.1016\/j.msard.2026.107219_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13760-018-0900-5","article-title":"Environmental risk factors in neuromyelitis optica spectrum disorder: a case\u2013control study","volume":"118","author":"Eskandarieh","year":"2018","journal-title":"Acta. Neurol. Belg."},{"key":"10.1016\/j.msard.2026.107219_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.msard.2017.01.004","article-title":"Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: a case-control study","volume":"12","author":"Eskandarieh","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107219_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103928","article-title":"Global assessment of characteristics of multiple sclerosis registries; a systematic review","volume":"63","author":"Ezabadi","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107219_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.540156","article-title":"AQP4-IgG and MOG-IgG related optic neuritis\u2014prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis","volume":"11","author":"Filippatou","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.msard.2026.107219_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103777","article-title":"Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years","volume":"61","author":"Ghadiri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107219_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104493","article-title":"Late-onset multiple sclerosis in Iran: a report on demographic and disease characteristics","volume":"70","author":"Ghadiri","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107219_bib0011","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.msard.2018.09.032","article-title":"Multiple sclerosis registries in Europe\u2013an updated mapping survey","volume":"27","author":"Glaser","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2026.107219_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183667","article-title":"Impact of clinical registries on quality of patient care and clinical outcomes: a systematic review","volume":"12","author":"Hoque","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.msard.2026.107219_bib0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107219_bib0014","article-title":"Identifying existing guidelines, frameworks, checklists, and recommendations for implementing patient-reported outcome measures: protocol for a scoping review","volume":"13","author":"Jayasinghe","year":"2024","journal-title":"JMIR Res. Protoc."},{"issue":"4","key":"10.1016\/j.msard.2026.107219_bib0015","article-title":"A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran","volume":"14","author":"Kashipazha","year":"2015","journal-title":"Iran J. Neurol."},{"key":"10.1016\/j.msard.2026.107219_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105685","article-title":"Neuromyelitis optica spectrum disorders registry system in Iran: validity of data sets","volume":"87","author":"Khodaie","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107219_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251363293","article-title":"Environmental risk factors of neuromyelitis optica spectrum disorder: a systematic review","volume":"18","author":"Mohammadi Lapevandani","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107219_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ane.12039","article-title":"A need for national registries and international collaborative research in multiple sclerosis","volume":"126","author":"Myhr","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.msard.2026.107219_bib0019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107219_bib0020","unstructured":"RE D.N.G., Leavy M. Registries for evaluating patient outcomes: a user's Guide: agency for healthcare research and quality (US); 2014."},{"key":"10.1016\/j.msard.2026.107219_bib0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.msard.2019.05.004","article-title":"The Argentinean multiple sclerosis registry (RelevarEM): methodological aspects and directions","volume":"32","author":"Rojas","year":"2019","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:42:16Z","timestamp":1780976536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826002555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"alternative-id":["S2211034826002555"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107219","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The national neuromyelitis optica spectrum disorders registry system of Iran (NMORI): Aspects and methodological dimensions","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107219"}}